Nir Naor
Independent DirectorMr. Nir Naor, CPA, CFA, MBA (IMD), LL.M, is Executive Vice President, Chief Financial Officer & Treasurer of Neuronetics, Inc. from July 23, 2026 and serves as its Corporate Secretary since August 11, 2026 and serves as its Principal Financial and Accounting Officer since August 11, 2026. Mr. Naor served as Chief Financial Officer of AxoGen, Inc. since December 06, 2023 until May 12, 2025. He is an Independent Director of Brainstorm Cell Therapeutics Inc. from June 20, 2023. He Joined Brainstorm Cell Therapeutics Inc. from June 20, 2023. Mr. Naor has global work experience as CFO and senior finance leader, with the majority of his career spent at U.S. and European corporations. He has a broad background that includes large pharma and biotech and has overseen organizations in annual spend. Mr. Naor previously served as the Chief Financial Officer of HMNC Brain Health from December 2021 to October 2022 and as the Chief Financial Officer of Arbor Pharmaceuticals from January 2021 to September 2021. He also founded the Portfolio Management function in UCB and later on became UCB's US CFO. Mr. Naor's was CFO experience includes IPO Preparedness projects, as well as leading turnarounds and finance transformations, while overseeing Finance, IT, Investor Relations, Contracting Pricing and Commercial Ops functions at AstraZeneca, UCB and Molnlycke Healthcare from October 2017 to January 2021. Prior to joining the industry, Nir worked as an Investment Banker, specializing in IPOs and MA and prior to that was a commercial Lawyer. In addition, Mr. Naor currently serves as an advisor and advisory-board member to several biotech and tech startups. Mr. Naor is a Certified Public Accountant (CPA), Chartered Financial Analyst (CFA) and Advocate. Mr. Naor served as Chief Financial Officer, U.S., of UCB from July 2016 to July 2017. Mr. Naor holds a Master of Business Administration from IMD Business School in Switzerland, a master’s degree in law (LL.M.) from Hamburg University in Germany and bachelor’s degrees in law (LL.B.) and in accounting from the Tel-Aviv University in Israel.
Positions
- Company NameBrainstorm Cell Therapeutics Inc.Stock CodeBCLIPositionIndependent DirectorColleagues
- CLChaim LebovitsPresident & CEO
- PJPeter J. PittsChief Strategic Regulatory and Policy Officer & Executive Chairman
- UYUri YablonkaExecutive VP, Chief Business Officer, Secretary & Director
- APAlla PatlisInterim CFO & Controller
- HHHartoun HartounianExecutive VP & COO
- IAIrit ArbelIndependent Vice Chair of the Board
- JCJerold ChunChairman of Scientific Advisory Board
- Company NameNeuronetics, Inc.Stock CodeSTIMPositionExecutive VP, CFO, Corporate Secretary, Principal Financial and Accounting Officer & TreasurerColleagues
- DLDaniel L. ReuversCEO, President & Director
- RARobert A. CascellaIndependent Chairman of the Board
- NNNir NaorExecutive VP, CFO, Corporate Secretary, Principal Financial and Accounting Officer & Treasurer
- RGRobert GreeneSenior Vice President of Sales
- CSCory S. AndersonExecutive Vice President & General Manager of Greenbrook
- GPGlenn P. MuirIndependent Director
- SLSheryl L. ConleyIndependent Director
- MRMegan R. RosengartenIndependent Director
